DDW IBS 2016 - ARCHIVED SYMPOSIUM

DDW ARCHIVED Symposium

PROGRAM Information

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with irritable bowel syndrome (IBS).

Educational Objectives

Upon completing this program, participants should be better able to:

Incorporate into clinical practice novel diagnostic tools to differentiate IBS from other common disorders and make a "positive" IBS diagnosis

Individualize nonpharmacologic treatment plans for IBS patients using evidence-based recommendations

Individualize pharmacologic treatment plans for IBS patients using evidence-based recommendations


For more information, email us at info@GiHealthFoundation.org, or call 1-877-782-4532.

A Gi Health Foundation Special event

(select a speaker to view their bio and disclosure)

Agenda

01:53 Introduction and Breaking Stories From DDW 2016

07:14  Field Report 1

Advances in Symptom-Based Diagnosis of IBS (Rome IV Update)

13:07  Case 1

Patient With Abdominal Discomfort and Chronic, Severe Diarrhea

Integrating Novel Diagnostic Strategies Into Clinical Practice: Serologic testing for post-infectious IBS, new tests for sucrase and lactase deficiency, and anorectal manometry

45:24  Field Report 2

Facilitating Patient-Physician Communication About GI Symptoms:
MyGiHealth Mobile App

45:59  Case 2

Patient With IBS-D Symptoms

Advances in Nonpharmacologic Treatment of IBS-D: Evidence-based use of FODMAPs, nutritional supplements, peppermint oil, and probiotics

Advances in Pharmacologic Treatment of IBS-D: Evidence-based use of rifaximin, eluxadoline, and ondansetron with conventional therapies

01:18:39  Panel Discussion and Q&A

01:24:33  Closing Remarks

This program is not affiliated with Digestive Disease Week®.
Supported by educational grants from Commonwealth Laboratories, LLC., and QOL Medical, LLC.

Provided by: